Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch repair-deficient (dMMR) solid tumors across multiple types. Most patients avo...

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study 🔬🧬🏥 www.news-medical.net/news/2025042... #CancerResearch #Immunotherapy #ClinicalTrial #Dostarlimab #NEJM #PrecisionMedicine #Oncology #dMMRCancers @nejm.org @mskcancercenter.bsky.social